Literature DB >> 16842869

The membrane proximal disulfides of the EGF receptor extracellular domain are required for high affinity binding and signal transduction but do not play a role in the localization of the receptor to lipid rafts.

Jennifer Macdonald1, Zhengzhe Li, Wanwen Su, Linda J Pike.   

Abstract

The EGF receptor is a transmembrane receptor tyrosine kinase that is enriched in lipid rafts. Subdomains I, II and III of the extracellular domain of the EGF receptor participate in ligand binding and dimer formation. However, the function of the cysteine-rich subdomain IV has not been elucidated. In this study, we analyzed the role of the membrane-proximal portion of subdomain IV in EGF binding and signal transduction. A double Cys-->Ala mutation that breaks the most membrane-proximal disulfide bond (Cys600 to Cys612), ablated high affinity ligand binding and substantially reduced signal transduction. A similar mutation that breaks the overlapping Cys596 to Cys604 disulfide had little effect on receptor function. Mutation of residues within the Cys600 to Cys612 disulfide loop did not alter the ligand binding or signal transducing activities of the receptor. Despite the fact that the C600,612A EGF receptor was significantly impaired functionally, this receptor as well as all of the other receptors with mutations in the region of residues 596 to 612 localized normally to lipid rafts. These data suggest that the disulfide-bonded structure of the membrane-proximal portion of the EGF receptor, rather than its primary sequence, is important for EGF binding and signaling but is not involved in localizing the receptor to lipid rafts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842869      PMCID: PMC2771566          DOI: 10.1016/j.bbamcr.2006.05.002

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  30 in total

1.  CR1/CR2 interactions modulate the functions of the cell surface epidermal growth factor receptor.

Authors:  Francesca Walker; Suzanne G Orchard; Robert N Jorissen; Nathan E Hall; Hui-Hua Zhang; Peter A Hoyne; Timothy E Adams; Terrance G Johns; Colin Ward; Thomas P J Garrett; Hong-Jian Zhu; Maureen Nerrie; Andrew M Scott; Edouard C Nice; Antony W Burgess
Journal:  J Biol Chem       Date:  2004-03-11       Impact factor: 5.157

2.  EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization.

Authors:  Kathryn M Ferguson; Mitchell B Berger; Jeannine M Mendrola; Hyun Soo Cho; Daniel J Leahy; Mark A Lemmon
Journal:  Mol Cell       Date:  2003-02       Impact factor: 17.970

3.  Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains.

Authors:  Hideo Ogiso; Ryuichiro Ishitani; Osamu Nureki; Shuya Fukai; Mari Yamanaka; Jae-Hoon Kim; Kazuki Saito; Ayako Sakamoto; Mio Inoue; Mikako Shirouzu; Shigeyuki Yokoyama
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

4.  Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha.

Authors:  Thomas P J Garrett; Neil M McKern; Meizhen Lou; Thomas C Elleman; Timothy E Adams; George O Lovrecz; Hong-Jian Zhu; Francesca Walker; Morry J Frenkel; Peter A Hoyne; Robert N Jorissen; Edouard C Nice; Antony W Burgess; Colin W Ward
Journal:  Cell       Date:  2002-09-20       Impact factor: 41.582

5.  Disabling receptor ensembles with rationally designed interface peptidomimetics.

Authors:  Alan Berezov; Jinqiu Chen; Qingdu Liu; Hong-Tao Zhang; Mark I Greene; Ramachandran Murali
Journal:  J Biol Chem       Date:  2002-05-14       Impact factor: 5.157

6.  Second cysteine-rich region of epidermal growth factor receptor contains targeting information for caveolae/rafts.

Authors:  Montarop Yamabhai; Richard G W Anderson
Journal:  J Biol Chem       Date:  2002-05-21       Impact factor: 5.157

7.  Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface.

Authors:  Jessica P Dawson; Mitchell B Berger; Chun-Chi Lin; Joseph Schlessinger; Mark A Lemmon; Kathryn M Ferguson
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

8.  A structure-based model for ligand binding and dimerization of EGF receptors.

Authors:  Peter Klein; Dawn Mattoon; Mark A Lemmon; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

9.  The tethered configuration of the EGF receptor extracellular domain exerts only a limited control of receptor function.

Authors:  Dawn Mattoon; Peter Klein; Mark A Lemmon; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205

10.  Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae.

Authors:  Tove Ringerike; Frøydis D Blystad; Finn O Levy; Inger H Madshus; Espen Stang
Journal:  J Cell Sci       Date:  2002-03-15       Impact factor: 5.285

View more
  5 in total

1.  Luciferase fragment complementation imaging of conformational changes in the epidermal growth factor receptor.

Authors:  Katherine S Yang; Ma Xenia G Ilagan; David Piwnica-Worms; Linda J Pike
Journal:  J Biol Chem       Date:  2009-01-26       Impact factor: 5.157

2.  Regulation of redox signaling by selenoproteins.

Authors:  Wayne Chris Hawkes; Zeynep Alkan
Journal:  Biol Trace Elem Res       Date:  2010-03-20       Impact factor: 3.738

3.  Caenorhabditis elegans SDF-9 enhances insulin/insulin-like signaling through interaction with DAF-2.

Authors:  Victor L Jensen; Patrice S Albert; Donald L Riddle
Journal:  Genetics       Date:  2007-07-29       Impact factor: 4.562

4.  The intracellular juxtamembrane domain of the epidermal growth factor (EGF) receptor is responsible for the allosteric regulation of EGF binding.

Authors:  Jennifer L Macdonald-Obermann; Linda J Pike
Journal:  J Biol Chem       Date:  2009-03-31       Impact factor: 5.157

5.  Modulating the structure of EGFR with UV light: new possibilities in cancer therapy.

Authors:  Manuel Correia; Viruthachalam Thiagarajan; Isabel Coutinho; Gnana Prakash Gajula; Steffen B Petersen; Maria Teresa Neves-Petersen
Journal:  PLoS One       Date:  2014-11-11       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.